Trials / Conditions / HPV-Related Squamous Cell Carcinoma

HPV-Related Squamous Cell Carcinoma

21 registered clinical trials studyying HPV-Related Squamous Cell Carcinoma — 8 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	CASCADE 2002: PROTECT Study, "PRObiotics to TrEat Anal preCancer Trial NCT06949800	University of California, San Francisco	Phase 2
Recruiting	E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers NCT05639972	Christian Hinrichs	Phase 1 / Phase 2
Withdrawn	Vorinostat in Combination With Chemoradiation in Locally Advanced HPV Negative HNSCC NCT05608369	Case Comprehensive Cancer Center	Phase 2
Not Yet Recruiting	Autologous T Cells Targeting HPV16 HPV18 & Survivin in Patients With R/R HPV-related Oropharyngeal Cancers NCT05582590	NexImmune Inc.	Phase 1
Not Yet Recruiting	Phase 1/2 Study of Autologous SCG142 TCR T Cells in Patients With HPV16/52-positive Carcinoma NCT06505551	SCG Cell Therapy Pte. Ltd.	Phase 1 / Phase 2
Recruiting	A Study Comparing Personalized Radiation Therapy With Standard Radiation Therapy in People With HPV-Positive T NCT06563479	Memorial Sloan Kettering Cancer Center	Phase 3
Active Not Recruiting	A Basket Study of Customized Autologous TCR-T Cell Therapies in Patients With Locally Advanced (Unresectable) NCT05973487	TScan Therapeutics, Inc.	Phase 1
Recruiting	E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers NCT05686226	Christian Hinrichs	Phase 2
Withdrawn	Alpelisib in Combination With Carboplatin in Patients With Solid Tumors and HPV-Positive Squamous Cell Carcino NCT05472220	Pamela Munster	Phase 1
Recruiting	Trial of Cemiplimab, or Cemip-Chemo Followed by Biomarker-guided Treatment for Pts w/HPV H&N Ca NCT04988074	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	Phase 2
Completed	HPV in Sinonasal Ca: Retrospective Analysis Association of Human Papilloma Virus (HPV) Serology and Behavioral NCT04979000	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	—
Recruiting	Risk-adapted Therapy in HPV+ Oropharyngeal Cancer Using Circulating Tumor (ct)HPV DNA Profile - The ReACT Stud NCT04900623	Jonathan Schoenfeld, MD, MPH	Phase 2
Active Not Recruiting	HPV-16 Vaccination and Pembrolizumab Plus Cisplatin for "Intermediate Risk" HPV-16-associated Head and Neck Sq NCT04369937	Dan Zandberg	Phase 2
Completed	IPI-549 in Patients With Locally Advanced HPV+ and HPV- Head and Neck Squamous Cell Carcinoma NCT03795610	Assuntina G. Sacco, MD	Phase 2
Completed	A Phase 1/2 Study in Patients With HPV16+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma and Other NCT04180215	Hookipa Biotech GmbH	Phase 1 / Phase 2
Completed	De-Escalation Therapy for Human Papillomavirus Negative Disease NCT03944915	University of Chicago	Phase 2
Unknown	Persistent Cervical HPV Infection With Clearance and Vaginal Microbiota NCT03895866	Peking Union Medical College Hospital	—
Unknown	Postmenopausal Women With Vaginal Microbiota NCT03786601	Peking Union Medical College Hospital	—
Withdrawn	PROGRESS Trial - Prophylactic Gabapentin for Relief of Symptoms and Improved Swallowing NCT03423264	University of Chicago	Phase 2
Unknown	A Safety and Efficacy Trial of Circumferential Anal Canal Radiofrequency Ablation for High-Grade Anal Intraepi NCT03302858	Stephen E. Goldstone	Phase 2
Completed	Chemotherapy and Locoregional Therapy Trial (Surgery or Radiation) for Patients With Head and Neck Cancer NCT03107182	University of Chicago	Phase 2